Te­va of­fi­cial­ly shut­ters the doors to a trou­bled South­ern Cal­i­for­nia site

3 years ago
Manufacturing

Mor­ton Grove Phar­ma­ceu­ti­cals to dis­con­tin­ue op­er­a­tions at Illi­nois site due to on­go­ing man­u­fac­tur­ing is­sues

3 years ago
Pharma
Manufacturing

So much to say, so lit­tle space. FDA-led stud­ies as­sess risk in­for­ma­tion on so­cial me­dia

3 years ago
Pharma
FDA+

FDA com­mis­sion­er spells out agen­cy's top pri­or­i­ties, with a fo­cus on dis­pelling mis­in­for­ma­tion

3 years ago
FDA+

Mar­ket­ingRx roundup: Pfiz­er press­es Comir­naty case for teens in new com­mer­cial; Idor­sia de­buts Olympic ski­er ad

3 years ago
Pharma
Marketing

Q&A: GSK vac­cine leader Judy Stew­art nav­i­gates vac­ci­na­tion slumps, al­ways-on mar­ket­ing and in­no­vat­ing da­ta tools

3 years ago
Pharma
Marketing

Dragged by PhI­II flop and shelved by Ab­b­Vie, a class of de­pres­sion drugs finds new life at start­up

3 years ago
Startups

No Q2 call yet for a Col­orado medtech; San Diego biotech col­labs with MD An­der­son

3 years ago
News Briefing

Covid-19 roundup: Pfiz­er/BioN­Tech add on vac­cine da­ta for young chil­dren; Mex­i­co says it's miss­ing vac­cine dos­es from ...

3 years ago
Coronavirus

Atara set to lay off 77 in Cal­i­for­nia as com­pa­ny seeks to re­duce cash burn, tran­si­tion in­to new phase

3 years ago
People

Mod­er­na launch­es ‘change mak­ers’ cam­paign with icon­ic ad­vo­cate

3 years ago
Pharma
Marketing

FDA con­verts Foghorn's par­tial hold on blood can­cer study to a full pause

3 years ago
R&D
FDA+

Biotech's 'sug­ar high' led to a cor­rec­tion, but win­ter dol­drums could make way for a turn­around sto­ry this fall

3 years ago
Financing
In Focus

Years af­ter Sanofi's Deng­vax­ia fi­as­co, Take­da lands first OK for its own dengue vac­cine

3 years ago
Pharma

British re­searchers be­hind RE­COV­ERY re­turn for mon­key­pox drug study, launch­ing ahead of NIH tri­al

3 years ago
R&D

Psy­che­delics start­up nets more than $10M in seed fund­ing as it looks to make a splash

3 years ago
Financing
Startups

Al­con, No­var­tis' for­mer eye dis­ease unit, con­tin­ues deal­mak­ing spree with $770M Aerie ac­qui­si­tion

3 years ago
Deals
R&D

Four of­fers and a call from Bourla: How Pfiz­er nar­row­ly beat out ri­val bid­der to swal­low GBT and its sick­le cell ...

3 years ago
Deals

Covid-19 roundup: Pfiz­er sub­mits EUA for Omi­cron-tar­get­ed boost­er; No­vavax EUA ex­pands to teens

3 years ago
Coronavirus

Med­ica­tion abor­tion man­u­fac­tur­er with­draws Mis­sis­sip­pi law­suit

3 years ago
Pharma
Law

CEO of Michi­gan CD­MO ex­plains how he nabbed mon­key­pox vac­cine con­tract

3 years ago
Outsourcing
Pharma

Charg­ing for ex­pand­ed ac­cess drugs: FDA to let com­pa­nies re­coup their costs over time

3 years ago
Pharma
FDA+

Ther­mo Fish­er opens new $105M bi­o­log­ics man­u­fac­tur­ing site out­side of Nashville

3 years ago
Pharma
Manufacturing

Not so fast, Te­va. Vi­for wins a few more years of pro­tec­tion from a po­ten­tial Velphoro gener­ic

3 years ago
Pharma
Law
First page Previous page 474475476477478479480 Next page Last page
A service from the Financial Times